LTCPA Policy Correspondence

LTCPA Letter to Senators Reid, Baucus, Dodd and Harkin Concerning H.R. 3590
  While we applaud the goal of reducing pharmaceutical waste, we remain concerned with the approach articulated in Section 3310 and the potential consequences such a policy may have on a vulnerable patient population that relies so heavily on accuracy and safety.
  Read The Letter (PDF) (PDF)
  Report Language for HR 3590 (PDF) (PDF)
   
LTCPA Outlines Part D Concerns In Letter to President-elect Obama
  LTCPA has written a letter to President-Elect Obama outlining concerns about how the Part D program is serving long term care residents.
Read the LTCPA Letter (PDF)
   
LTCPA Responds to CMS Survey Letter of May 11th
  CMS released a letter to state nursing home survey agencies on issues related to Medicare Part D. LTCPA calls on CMS to withdraw this document.
Read the LTCPA Response (PDF)
   
Bipartisan Group of House Members Urges CMS to Revise Its Marketing Guidelines
  A bipartisan group including Congressmen English, Waxman, Ramstad, Bilirakis, and Strickland have sent a letter to CMS Adminstrator McClellan urging the Part D marketing guidelines be revised to allow LTC health professionals to assist residents in selecting the best plan for their needs.
English Marketing Guidelines Letter (PDF)
   
LTCPA, NABP Oppose Pennsylvania Bill Requiring LTC Pharmacies to Dispense Repackaged Drugs
  A coalition of pharmacy groups including LTCPA,the National Boards of Pharmacy, and Pennslylvania Pharmacists Association have written state lawmakers in opposition to H.B. 1022, a bill requiring LTC pharmacies to repackage drugs from outside sources.
LTCPA's Letter (PDF)
NABP's Letter (DOC)